WGS Insider Filing: 2,462 RSUs Settled; Sell-to-Cover Executed at ~$128
Rhea-AI Filing Summary
GeneDx Holdings Corp. (WGS) insider filing shows CFO Kevin Feeley reported the vesting and settlement of 2,462 RSUs on 09/09/2025, which represent contingent rights to Class A common stock settled for $0 per share. To satisfy tax withholding on the settlement, the reporting person executed two sell transactions that disposed of 1,266 shares at $128.05 and 6 shares at $129.09. After these transactions Mr. Feeley beneficially owned 5,286 shares of Class A common stock directly, plus RSUs representing up to 131,830 shares and options covering 27,152 shares that vest per their terms.
Positive
- Substantial retained equity: Reporting person retains RSUs representing 131,830 shares and options for 27,152 shares, indicating continued alignment with shareholders.
- Transaction transparency: Filing discloses the sell-to-cover nature and provides prices ($128.05 and $129.09), clarifying these were for tax withholding and not discretionary divestitures.
Negative
- Reduction in direct shares: Direct holdings declined from 6,558 to 5,286 shares following the reported sales.
- Immediate dilution potential: Settlement of RSUs (2,462 shares) and large outstanding awards (131,830 RSUs and 27,152 options) could increase share count upon vesting/exercise.
Insights
TL;DR: Routine vesting and sell-to-cover tax withholding; significant latent equity remains via RSUs and options.
The Form 4 documents a non-discretionary sell-to-cover tied to the settlement of 2,462 RSUs, producing modest share disposals (1,272 shares total) at market prices of $128.05 and $129.09. These transactions reduce direct holdings but do not materially change the reporting person’s long-term economic exposure because substantial unvested RSUs (131,830 shares) and options (27,152 shares) remain outstanding. For investors, this is an expected administrative action, not an active stock-sale signal.
TL;DR: Disclosure aligns with Section 16 requirements; transactions are tax-related and executed under standard procedures.
The filing clearly states the sales were executed to satisfy tax-withholding obligations from RSU settlement and were not discretionary. The form identifies the reporting person as the CFO and confirms continued beneficial ownership through direct shares plus material unvested equity awards. Documentation appears complete with explanatory footnotes and an attorney-in-fact signature, meeting typical governance and disclosure standards.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 2,462 | $0.00 | -- |
| Exercise | Class A Common Stock | 2,462 | $0.00 | -- |
| Sale | Class A Common Stock | 1,266 | $128.05 | $162K |
| Sale | Class A Common Stock | 6 | $129.09 | $774.54 |
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Following the reported sales, in addition to the 5,286 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 131,830 shares of Class A common stock and options to purchase up to an aggregate of 27,152 shares of Class A common stock, which RSUs and options vest according to their respective terms. 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
